Literature DB >> 2715605

Neurological complications of hemolytic-uremic syndrome.

J S Hahn1, P L Havens, J J Higgins, P P O'Rourke, J A Estroff, R Strand.   

Abstract

Of 78 children identified with hemolytic-uremic syndrome at the Children's Hospital, Boston, from 1976 to 1986, 16 patients (20.5%) had neurological manifestations during their hospitalization. The most common manifestations were significant alterations in consciousness (coma, stupor) in 12 patients, and either generalized or partial seizures in ten patients. Others included hemiplegia (4 patients), decerebrate posturing (3), cortical blindness (2), hallucinations (1), and dystonic posturing (1). Cranial computed tomographic scans were abnormal in eight of 11 patients scanned. The abnormalities included diffuse cerebral edema (4 patients), large vessel infarctions (3), diffuse multiple small infarcts (4), and multiple hemorrhages (1). Five patients died as a result of their central nervous system complications, and six had neurological sequelae at discharge. Five patients recovered and at discharge had no evidence of neurological dysfunction.

Entities:  

Mesh:

Year:  1989        PMID: 2715605     DOI: 10.1177/088307388900400206

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  29 in total

1.  Early-onset combined methylmalonic aciduria and homocystinuria: neuroradiologic findings.

Authors:  A Rossi; R Cerone; R Biancheri; R Gatti; M C Schiaffino; C Fonda; E Zammarchi; P Tortori-Donati
Journal:  AJNR Am J Neuroradiol       Date:  2001-03       Impact factor: 3.825

Review 2.  Neurological and Neurosurgical Emergencies in Patients with Hematological Disorders.

Authors:  Martha L Cruz; Shama Farooq; Fernando D Testai
Journal:  Curr Neurol Neurosci Rep       Date:  2017-03       Impact factor: 5.081

3.  Neuropsychological sequelae of haemolytic uraemic syndrome. Investigators of the HUS Cognitive Study.

Authors:  A Schlieper; E Orrbine; G A Wells; M Clulow; P N McLaine; P C Rowe
Journal:  Arch Dis Child       Date:  1999-03       Impact factor: 3.791

4.  Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome.

Authors:  Sylvie Nathanson; Thérésa Kwon; Monique Elmaleh; Marina Charbit; Emma Allain Launay; Jérôme Harambat; Muriel Brun; Bruno Ranchin; Flavio Bandin; Sylvie Cloarec; Guylhene Bourdat-Michel; Christine Piètrement; Gérard Champion; Tim Ulinski; Georges Deschênes
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-24       Impact factor: 8.237

5.  Myocarditis and haemolytic uraemic syndrome.

Authors:  I Abu-Arafeh; E Gray; G Youngson; I Auchterlonie; G Russell
Journal:  Arch Dis Child       Date:  1995-01       Impact factor: 3.791

6.  Hemolytic uremic syndrome: MR findings of CNS complications.

Authors:  Y K Jeong; I O Kim; W S Kim; Y S Hwang; Y Choi; K M Yeon
Journal:  Pediatr Radiol       Date:  1994

7.  Angiopoietin-1 and -2 as markers for disease severity in hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli.

Authors:  Masaki Shimizu; Natsumi Inoue; Mondo Kuroda; Mao Mizuta; Naotoshi Sugimoto; Hisashi Kaneda; Kazuhide Ohta; Akihiro Yachie
Journal:  Clin Exp Nephrol       Date:  2016-03-05       Impact factor: 2.801

8.  Isolated abducens nerve palsy in hemolytic uremic syndrome.

Authors:  Anne Durkan; Shay Menascu; Valerie Langlois
Journal:  Pediatr Nephrol       Date:  2004-06-04       Impact factor: 3.714

9.  Cerebral infarct with recurrence of hemolytic-uremic syndrome in a child following renal transplantation.

Authors:  M Mochon; B A Kaiser; J P deChadarevian; M S Polinsky; H J Baluarte
Journal:  Pediatr Nephrol       Date:  1992-11       Impact factor: 3.714

10.  Shiga toxin 2 affects the central nervous system through receptor globotriaosylceramide localized to neurons.

Authors:  Fumiko Obata; Koujiro Tohyama; Adrian D Bonev; Glynis L Kolling; Tiffany R Keepers; Lisa K Gross; Mark T Nelson; Shigehiro Sato; Tom G Obrig
Journal:  J Infect Dis       Date:  2008-11-01       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.